Total Positions
64
Quarter
2025 Q4
Top Holding
CDTX (10.1%)
Top 10 Concentration
57.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 64
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 10.06% | 6.46% |
#1
1
Prev: #2
|
6.1 | 16,635 | 24.3% |
P
S
|
85,098 | $18,797,297 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 9.60% | 5.84% |
#2
1
Prev: #3
|
4.0 | -345,869 | -43.8% |
P
S
|
443,777 | $17,928,591 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 9.01% | 1.73% |
#3
20
Prev: #23
|
5.9 | 630,442 | 717.1% |
P
S
|
718,354 | $16,823,851 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 6.96% | 5.11% |
#4
3
Prev: #7
|
4.8 | 4,830 | 1.3% |
P
S
|
366,238 | $13,008,774 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DVAX
DYNAVAX TECHNOL...
|
Healthcare | 4.33% | — |
#5
Prev: #—
|
3.7 | 525,592 | no change |
NEW
|
525,592 | $8,083,605 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 3.98% | — |
#6
Prev: #—
|
3.6 | 180,593 | no change |
NEW
|
180,593 | $7,429,596 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 3.93% | 5.42% |
#7
2
Prev: #5
|
1.6 | -52,671 | -15.4% |
P
S
|
288,677 | $7,338,169 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 3.66% | — |
#8
Prev: #—
|
3.5 | 37,433 | no change |
NEW
|
37,433 | $6,836,763 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SVRA
SAVARA INC
|
Healthcare | 3.21% | 4.60% |
#9
1
Prev: #8
|
1.4 | -313,883 | -24.0% |
P
S
|
995,353 | $6,001,979 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MNMD
MIND MEDICINE M...
|
Healthcare | 3.05% | — |
#10
Prev: #—
|
3.2 | 425,202 | no change |
NEW
|
425,202 | $5,693,455 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 2.89% | — |
#11
Prev: #—
|
3.2 | 980,768 | no change |
NEW
|
980,768 | $5,394,224 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 2.72% | — |
#12
Prev: #—
|
3.1 | 418,080 | no change |
NEW
|
418,080 | $5,075,491 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 2.69% | — |
#13
Prev: #—
|
3.1 | 352,896 | no change |
NEW
|
352,896 | $5,025,239 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CABA
CABALETTA BIO I...
|
Healthcare | 2.64% | 3.56% |
#14
2
Prev: #12
|
3.2 | 709,025 | 45.9% |
P
S
|
2,253,550 | $4,935,275 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.47% | — |
#15
Prev: #—
|
3.0 | 9,451 | no change |
NEW
|
9,451 | $4,605,000 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 2.34% | — |
#16
Prev: #—
|
2.9 | 54,879 | no change |
NEW
|
54,879 | $4,371,112 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BLTE
BELITE BIO INC
|
Healthcare | 2.12% | — |
#17
Prev: #—
|
2.8 | 24,703 | no change |
NEW
|
24,703 | $3,951,492 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 1.98% | 3.22% |
#18
4
Prev: #14
|
0.8 | -6,672 | -12.4% |
P
S
|
47,278 | $3,689,575 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZLAB
ZAI LAB LTD
|
Healthcare | 1.86% | 6.70% |
#19
18
Prev: #1
|
0.7 | -3,775 | -1.9% |
P
S
|
196,853 | $3,472,487 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 1.62% | 2.11% |
#20
Prev: #20
|
0.7 | -13,312 | -13.8% |
P
S
|
83,353 | $3,026,547 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QNCX
QUINCE THERAPEU...
|
Healthcare | 1.54% | — |
#21
Prev: #—
|
2.6 | 858,711 | no change |
NEW
|
858,711 | $2,876,682 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.49% | 2.36% |
#22
4
Prev: #18
|
0.7 | -34,767 | -18.5% |
P
S
|
153,313 | $2,784,164 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAPR
CAPRICOR THERAP...
|
Healthcare | 1.49% | — |
#23
Prev: #—
|
2.6 | 96,334 | no change |
NEW
|
96,334 | $2,780,199 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 1.43% | — |
#24
Prev: #—
|
2.6 | 25,469 | no change |
NEW
|
25,469 | $2,665,840 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.28% | — |
#25
Prev: #—
|
2.5 | 88,308 | no change |
NEW
|
88,308 | $2,398,445 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ETNB
89BIO INC
|
Unknown | 0.00% | 5.57% |
Sold All 😨
(Was: #4) |
0.3 | -384,652 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 0.00% | 5.31% |
Sold All 😨
(Was: #6) |
0.3 | -40,893 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 0.00% | 4.54% |
Sold All 😨
(Was: #9) |
0.3 | -88,658 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SMMT
SUMMIT THERAPEU...
|
Healthcare | 0.00% | 4.01% |
Sold All 😨
(Was: #10) |
0.3 | -197,253 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IQV
IQVIA HLDGS INC
|
Healthcare | 0.00% | 3.58% |
Sold All 😨
(Was: #11) |
0.3 | -19,114 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 0.00% | 3.55% |
Sold All 😨
(Was: #13) |
0.3 | -6,401 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.00% | 2.87% |
Sold All 😨
(Was: #15) |
0.3 | -51,270 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
INSMED INC
|
Healthcare | 0.00% | 2.81% |
Sold All 😨
(Was: #16) |
0.3 | -19,786 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BCAX
BICARA THERAPEU...
|
Healthcare | 0.00% | 2.74% |
Sold All 😨
(Was: #17) |
0.3 | -175,902 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNY
SANOFI SA
|
Healthcare | 0.00% | 2.34% |
Sold All 😨
(Was: #19) |
0.3 | -50,407 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QURE
UNIQURE NV
|
Healthcare | 0.00% | 1.91% |
Sold All 😨
(Was: #21) |
0.3 | -33,175 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.00% | 1.84% |
Sold All 😨
(Was: #22) |
0.3 | -119,286 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KROS
KEROS THERAPEUT...
|
Healthcare | 0.00% | 1.48% |
Sold All 😨
(Was: #25) |
0.3 | -95,083 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 0.00% | 1.45% |
Sold All 😨
(Was: #26) |
0.3 | -39,521 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 0.00% | 1.33% |
Sold All 😨
(Was: #27) |
0.3 | -20,358 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 0.00% | 0.88% |
Sold All 😨
(Was: #30) |
0.3 | -34,449 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 0.00% | 0.85% |
Sold All 😨
(Was: #31) |
0.3 | -150,312 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 0.00% | 0.72% |
Sold All 😨
(Was: #32) |
0.3 | -57,644 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMAB
I MAB
|
Unknown | 0.00% | 0.52% |
Sold All 😨
(Was: #33) |
0.3 | -139,886 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 64 holdings